Back

Use of vericiguat: real-world outcomes and insights from the VERITA registry.

31 August 2025 (11:15 - 12:00)
Organised by: Logo
Congress Presentation Part of: Improving outcomes in heart failure Pharmacotherapy ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Mario Galvan Ruiz

University Hospital Dr Negrin, Las Palmas de Gran Canaria (Spain)

6 More presentations in this session

Presentation thumbnail
Predicting heart failure hospitalization and death in patients with heart failure with reduced ejection fraction using the modified GDMT score: a retrospective, single-center study
Mr T. Buppodom (Hat Yai, TH)
Abstract Slides Video
Presentation thumbnail
QRS complex fragmentation before and after cardiac resynchronization therapy as a predictor of heart failure hospitalizations: differences between ischaemic and non-ischaemic aetiologies
Doctor J. Larre Guerra (Madrid, ES)
Abstract Slides Video
Presentation thumbnail
Trends in guideline-directed medical therapy and clinical outcomes in Taiwanese heart failure patients: insight from the TSOC HF registry 2020
Doctor H. Chang (Taipei, TW)
Abstract Slides Video
Presentation thumbnail
Comparison of the effects of two training modalities: home-based telemonitored walking training vs. cycle ergometer training on exercise capacity and inflammatory biomarkers in heart failure patients
Professor E. Piotrowicz (Warsaw, PL)
Abstract Slides Video
Presentation thumbnail
Implementation of a transitional care programme for heart failure and its impact on 30-day readmissions and emergency department visits
Doctor M. Albaghdadi (London, CA)
Abstract Slides Video

Access the full session

Session thumbnail
Improving outcomes in heart failure

The Event

Event poster

ESC Congress 2025

31 August 2025 11:15 CET
You may be interested in
thumbnail
Congress Presentation
Impact of vericiguat use in real life. New insight of the VERITA registry.
thumbnail
Congress Presentation
Vericiguat in a real-world heart failure population: a single-centre experience
thumbnail
Congress Presentation
Initial experience with vericiguat treatment in real life. VERITA registry versus the VICTORIA study.

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources